Burning Rock Biotech
BNR
$0.81
Share price
6.38%
Change (1 day)
-72.27%
Change (1 year)
Categories
Burning Rock Biotech (BNR) - Cash on Hand
Cash on Hand as of September 2023 : $88.82 M
According to Burning Rock Biotech's latest financial reports the company has $88.82 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Burning Rock Biotech - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.13 B | -44.05% |
| 2021-12-31 | $0.23 B | -32.21% |
| 2020-12-31 | $0.34 B | 492.29% |
| 2019-12-31 | $58.43 M | 208.84% |
| 2018-12-31 | $18.92 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 LabCorp LH | $0.53 B | 504.35% | 🇺🇸 USA |
 OpGen
OPGN | $0.29 M | -99.67% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.41 B | 367.45% | 🇺🇸 USA |